Intrinsic Value

Is NeoPharm Co Ltd undervalued or overvalued?

See the intrinsic value estimate for NeoPharm Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

NeoPharm Co Ltd Intrinsic Value
LOCKED
Unlock
Today vs. history

NeoPharm Co Ltd looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with NeoPharm Co Ltd’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor NeoPharm Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price ₩23 150
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to NeoPharm Co Ltd

Fundamental Analysis

What NeoPharm Does

Consumer products Consumer Staples

NeoPharm Co Ltd is a South Korean healthcare company that makes and sells medicines and skin-care products. Its product line is centered on prescription and over-the-counter drugs, along with items used for skin health, wound care, and daily treatment needs. The company earns money mainly by selling these products through healthcare and retail channels.

Headquarters
Korea KR
IPO date
Jan 30, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
NeoPharm Co Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one NeoPharm Co Ltd stock?

The intrinsic value for NeoPharm Co Ltd (092730) under the Base Case is hidden KRW.

Is NeoPharm Co Ltd stock undervalued or overvalued?

Compared with the current market price of 23 150 KRW, the stock appears hidden.

Back to Top